AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32264706 — intervention group
Group type: COMPARATOR
Intervention: Observation (Group II)
Number of subjects: 52
Study 32191755 — intervention group
Group type: EXPERIMENTAL
Intervention: Static stretching
Number of subjects: 15
Study 32191755 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic muscle activity
Number of subjects: 15
Study 32191755 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 15
Study 35802749 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-MA injections once a week
Number of subjects: 180
Study 35802749 — intervention group
Group type: COMPARATOR
Intervention: IL-MA injections twice a week
Number of subjects: 180
Study 34660472 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine group (0.2% ropivacaine + 0.5 μg/kg dexmedetomidine)
Number of subjects: 80
Study 34660472 — intervention group
Group type: COMPARATOR
Intervention: Control group (0.2% ropivacaine alone)
Number of subjects: 80
Study 34660472 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine group
Number of subjects: 80
Study 34660472 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study 34809666 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised high-intensity functional exercise programme (HIFE) executed twice weekly over 12 weeks
Number of subjects: 127
Study 34809666 — intervention group
Group type: EXPERIMENTAL
Intervention: Written information and an additional supervised high-intensity functional exercise programme (HIFE)
Number of subjects: 127
Study 34809666 — intervention group
Group type: COMPARATOR
Intervention: Written exercise information (control group)
Number of subjects: 127
Study 33181782 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin-guided antibiotic treatment algorithm
Number of subjects: 270
Study 33181782 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 270
Study 33181782 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin arm
Number of subjects: 270
Study 32374504 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy followed by surgery (NACS)
Number of subjects: 440
Study 32374504 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandard tumour regression grade (TRG)
Number of subjects: 440
Study 34615741 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle positioning gait biofeedback (GBF)
Number of subjects: 18
Study 34615741 — intervention group
Group type: COMPARATOR
Intervention: Without biofeedback
Number of subjects: 18
Study 33515130 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer risk assessment (CRA) feedback
Number of subjects: 419
Study 35811372 — intervention group
Group type: EXPERIMENTAL
Intervention: AlloCB group received 10 × 10^7 AlloCB total nucleated cells (TNC) per kilogram at baseline (n = 31)
Number of subjects: 91
Study 35811372 — intervention group
Group type: EXPERIMENTAL
Intervention: hCT-MSC group received 2 × 10^6 hCT-MSC at baseline, 3 months, and 6 months (n = 28)
Number of subjects: 91
Study 35811372 — intervention group
Group type: COMPARATOR
Intervention: Natural history control group received 10 × 10^7 AlloCB TNC per kilogram at 12 months (n = 31)
Number of subjects: 91
Study 35811372 — intervention group
Group type: COMPARATOR
Intervention: hCT-MSC group compared to natural history control
Number of subjects: 91
Study 35811372 — intervention group
Group type: COMPARATOR
Intervention: AlloCB group compared to natural history control
Number of subjects: 91
Study 32299792 — intervention group
Group type: EXPERIMENTAL
Intervention: E-learning module
Number of subjects: 39
Study 32299792 — intervention group
Group type: COMPARATOR
Intervention: NIHSS video
Number of subjects: 39
Study 35236568 — intervention group
Group type: EXPERIMENTAL
Intervention: High tumour-infiltrating lymphocytes (TILs) prevalence (TILshigh)
Number of subjects: 711
Study 35236568 — intervention group
Group type: EXPERIMENTAL
Intervention: High TILs in HER2-negative DCIS
Number of subjects: 711
Study 35236568 — intervention group
Group type: EXPERIMENTAL
Intervention: Including TILs-status in clinical workup
Number of subjects: 711
Study 33543410 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive strength training 3 times/week (3 × 10 repetitions at 80% of one‐repetition maximum)
Number of subjects: 179
Study 33543410 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength endurance training (2 × 30 repetitions at 40% of one‐repetition maximum)
Number of subjects: 179
Study 33543410 — intervention group
Group type: COMPARATOR
Intervention: Control (passive stretching exercise)
Number of subjects: 179
Study 33543410 — intervention group
Group type: EXPERIMENTAL
Intervention: AHTD users
Number of subjects: 179
Study 33543410 — intervention group
Group type: EXPERIMENTAL
Intervention: ARB users
Number of subjects: 179
Study 33543410 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin users
Number of subjects: 179
Study 32088746 — intervention group
Group type: EXPERIMENTAL
Intervention: Fexapotide triflutate 2.5 mg
Number of subjects: 146
Study 32088746 — intervention group
Group type: EXPERIMENTAL
Intervention: Fexapotide triflutate 15 mg
Number of subjects: 146
Study 32088746 — intervention group
Group type: COMPARATOR
Intervention: Control Active Surveillance
Number of subjects: 146
Study 34402360 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous combined estradiol 0.5 mg + dydrogesterone 2.5 mg
Number of subjects: 332
Study 34402360 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 332
Study 32667105 — intervention group
Group type: EXPERIMENTAL
Intervention: MICRA (Motivational Interviewing and Community Reinforcement Approach)
Number of subjects: 79
Study 32667105 — intervention group
Group type: COMPARATOR
Intervention: TAU (Treatment as Usual)
Number of subjects: 79
Study 34365978 — intervention group
Group type: COMPARATOR
Intervention: Berberine (Be)
Number of subjects: 300
Study 34365978 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium (Bi)
Number of subjects: 300
Study 34365978 — intervention group
Group type: COMPARATOR
Intervention: Berberine and Bifidobacterium (BB)
Number of subjects: 300
Study 34365978 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 32398130 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication skills training (group training)
Number of subjects: 0
Study 32398130 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group (CG)
Number of subjects: 0
Study 32398130 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication skills training
Number of subjects: 0
Study 35942523 — intervention group
Group type: EXPERIMENTAL
Intervention: text+visual intervention
Number of subjects: 145
Study 35942523 — intervention group
Group type: EXPERIMENTAL
Intervention: text-only intervention
Number of subjects: 145
Study 35942523 — intervention group
Group type: COMPARATOR
Intervention: control
Number of subjects: 145
Study 34785173 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nicorandil (6 mg as a bolus before reperfusion, followed by 48 hours of continuous infusion at a dose of 6 mg/h)
Number of subjects: 1500
Study 34785173 — intervention group
Group type: COMPARATOR
Intervention: Placebo (same dosage as nicorandil)
Number of subjects: 1500
Study 34785173 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nicorandil
Number of subjects: 1500
Study 34785173 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1500
Study 32871687 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness Meditation, Reiki, Acupuncture, and Auriculotherapy (experimental group)
Number of subjects: 21
Study 32871687 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 21
Study 33794164 — intervention group
Group type: EXPERIMENTAL
Intervention: Sutureless surgical valve
Number of subjects: 680
Study 33794164 — intervention group
Group type: COMPARATOR
Intervention: Sutured surgical valve
Number of subjects: 680
Study 34540991 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate beverage administered 2 hours before endoscopy
Number of subjects: 180
Study 34540991 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate beverage administered 4 hours before endoscopy
Number of subjects: 180
Study 34540991 — intervention group
Group type: COMPARATOR
Intervention: Control group (no carbohydrate supplementation for 8 hours before endoscopy)
Number of subjects: 180
Study 36116674 — intervention group
Group type: COMPARATOR
Intervention: 5.25% NaOCl + 17% EDTA (Control)
Number of subjects: 40
Study 36116674 — intervention group
Group type: EXPERIMENTAL
Intervention: Zn(II) Ce6 methyl ester + 17% EDTA
Number of subjects: 40
Study 36116674 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 nm femtosecond laser + 17% EDTA
Number of subjects: 40
Study 36116674 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin activated by PDT + 17% EDTA
Number of subjects: 40
Study 32123242 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) for 15 weeks
Number of subjects: 55
Study 32123242 — intervention group
Group type: COMPARATOR
Intervention: Sedentary Control
Number of subjects: 55
Study 33848338 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg THC and 0.06 mg CBD daily (Treatment A)
Number of subjects: 41
Study 33848338 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg THC and 0.12 mg CBD daily (Treatment B)
Number of subjects: 41
Study 33848338 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg THC and 0.18 mg CBD daily (Treatment C)
Number of subjects: 41
Study 33848338 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg THC and 0.24 mg CBD daily (Treatment D)
Number of subjects: 41
Study 33848338 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 33848338 — intervention group
Group type: COMPARATOR
Intervention: Treatment D vs Placebo
Number of subjects: 41
Study 33848338 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment A vs Treatment B
Number of subjects: 41
Study 33848338 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment B vs Treatment D
Number of subjects: 41
Study 33276789 — intervention group
Group type: EXPERIMENTAL
Intervention: Interprofessional case-based learning
Number of subjects: 0
Study 33276789 — intervention group
Group type: COMPARATOR
Intervention: Monoprofessional case-based learning
Number of subjects: 0
Study 32638095 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectant management
Number of subjects: 174
Study 32638095 — intervention group
Group type: COMPARATOR
Intervention: Misoprostol (800 µg single dose)
Number of subjects: 174
Study 35674652 — intervention group
Group type: EXPERIMENTAL
Intervention: Asynchronous telehealth visits
Number of subjects: 23
Study 32663286 — intervention group
Group type: EXPERIMENTAL
Intervention: App-based mindfulness-meditation program (10 min daily for 30 days)
Number of subjects: 46
Study 32023539 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (5,000 IU daily for 12 weeks)
Number of subjects: 19
Study 32023539 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 35037520 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-mediated intervention (Social ABCs)
Number of subjects: 179
Study 34698499 — intervention group
Group type: EXPERIMENTAL
Intervention: Belimumab
Number of subjects: 52
Study 34698499 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 32026827 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive exercise programme
Number of subjects: 708
Study 32026827 — intervention group
Group type: COMPARATOR
Intervention: Best-practice advice
Number of subjects: 708
Study 35150309 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifamily group intervention
Number of subjects: 72
Study 35150309 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 72
Study 34194315 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG-based neurofeedback training to enhance upper alpha frequency
Number of subjects: 0
Study 34194315 — intervention group
Group type: COMPARATOR
Intervention: Random feedbacks (Sham group)
Number of subjects: 0
Study 35149112 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk priming group
Number of subjects: 147
Study 35149112 — intervention group
Group type: EXPERIMENTAL
Intervention: Effectiveness priming group
Number of subjects: 147
Study 35149112 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 147
Study 32102725 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT)
Number of subjects: 37
Study 32102725 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 37
Study 34319427 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calorie diets containing 20% fat and 25% protein
Number of subjects: 540
Study 34319427 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calorie diets containing 40% fat and 15% protein
Number of subjects: 540
Study 34319427 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calorie diets with varying carbohydrate percentages
Number of subjects: 540
Study 35692982 — intervention group
Group type: EXPERIMENTAL
Intervention: True natural cycle (true NC‐) frozen embryo transfer (FET) using urinary LH tests
Number of subjects: 1464
Study 35692982 — intervention group
Group type: COMPARATOR
Intervention: Modified natural cycle (mNC‐FET) using repeated ultrasound monitoring and ovulation trigger
Number of subjects: 1464
Study 35692982 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost estimation based on resource use and unit prices
Number of subjects: 1464
Study 35692982 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal outcomes
Number of subjects: 1464
Study 33452056 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal contraceptive (HC) use with self-reported adverse mood symptoms
Number of subjects: 302
Study 33452056 — intervention group
Group type: COMPARATOR
Intervention: Women without self-reported HC-induced adverse mood symptoms
Number of subjects: 302
Study 32701587 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy interventions aimed at improving walking speed
Number of subjects: 227
Study 32701587 — intervention group
Group type: COMPARATOR
Intervention: Journals' Impact Factor
Number of subjects: 227
Study 32701587 — intervention group
Group type: COMPARATOR
Intervention: Open access journals endorsing CONSORT recommendations
Number of subjects: 227
Study 36058201 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol (10 mg hydrocortisone)
Number of subjects: 78
Study 36058201 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 32915009 — intervention group
Group type: EXPERIMENTAL
Intervention: Deliberate Practice (DP) workshop
Number of subjects: 68
Study 32915009 — intervention group
Group type: COMPARATOR
Intervention: Traditional workshop
Number of subjects: 68
Study 32915009 — intervention group
Group type: COMPARATOR
Intervention: Both groups (DP and Traditional)
Number of subjects: 68
Study 32915009 — intervention group
Group type: COMPARATOR
Intervention: Simulators (both groups)
Number of subjects: 68
Study 32439141 — intervention group
Group type: EXPERIMENTAL
Intervention: NICE guidelines
Number of subjects: 46
Study 32439141 — intervention group
Group type: COMPARATOR
Intervention: ESVS guidelines
Number of subjects: 46
Study 36151864 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (apremilast 10 mg to 60 mg + phototherapy)
Number of subjects: 42
Study 36151864 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy (phototherapy only)
Number of subjects: 42
Study 36151864 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 42
Study 36151864 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy
Number of subjects: 42
Study 33918724 — intervention group
Group type: EXPERIMENTAL
Intervention: BMGIM music therapy (8 sessions over 8 weeks)
Number of subjects: 43
Study 33918724 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 43
Study 34773428 — intervention group
Group type: EXPERIMENTAL
Intervention: Wind turbine noise at sound pressure levels of 33 dBA, 38 dBA, and 43 dBA
Number of subjects: 23
Study 34773428 — intervention group
Group type: COMPARATOR
Intervention: Road traffic noise at sound pressure levels of 33 dBA, 38 dBA, and 43 dBA
Number of subjects: 23
Study 33196566 — intervention group
Group type: EXPERIMENTAL
Intervention: Apex-centered capsulotomy
Number of subjects: 40
Study 33196566 — intervention group
Group type: COMPARATOR
Intervention: Standard pupil-centered capsulotomy
Number of subjects: 40
Study 33296365 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine deworming combined with a behaviour change intervention promoting handwashing with water and soap.
Number of subjects: 320
Study 33296365 — intervention group
Group type: COMPARATOR
Intervention: Routine deworming (control group).
Number of subjects: 320
Study 35347418 — intervention group
Group type: EXPERIMENTAL
Intervention: Live music therapy (4-week duration)
Number of subjects: 62
Study 35347418 — intervention group
Group type: EXPERIMENTAL
Intervention: Live music therapy
Number of subjects: 62
Study 35347418 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 62
Study 33536545 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant use (specific types include fluoxetine, paroxetine, escitalopram, venlafaxine, mirtazapine)
Number of subjects: 7230
Study 35586878 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU augmented with meditation and yoga training (MYT)
Number of subjects: 145
Study 35586878 — intervention group
Group type: COMPARATOR
Intervention: TAU
Number of subjects: 145
Study 35586878 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU augmented with Yoga training (YT)
Number of subjects: 145
Study 34323984 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician-facing intervention providing information about patient analgesic treatment preference and risk of opioid misuse.
Number of subjects: 1302
Study 34323984 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who preferred opioids (Black patients)
Number of subjects: 1302
Study 34323984 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who did not prefer opioids (Black patients)
Number of subjects: 1302
Study 35889747 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Arthrospira at 3 g daily
Number of subjects: 60
Study 35889747 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Arthrospira at 6 g daily
Number of subjects: 60
Study 35889747 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Arthrospira)
Number of subjects: 60
Study 33682549 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Kegel and yoga exercise for 3 months
Number of subjects: 74
Study 33682549 — intervention group
Group type: COMPARATOR
Intervention: Kegel exercise
Number of subjects: 74
Study 32843164 — intervention group
Group type: EXPERIMENTAL
Intervention: IND/GLY/MF high-dose (150/50/160 μg) once-daily
Number of subjects: 0
Study 32843164 — intervention group
Group type: EXPERIMENTAL
Intervention: IND/GLY/MF medium-dose (150/50/80 μg) once-daily
Number of subjects: 0
Study 32843164 — intervention group
Group type: COMPARATOR
Intervention: SAL/FLU high-dose (50/500 μg) twice-daily + TIO 5 μg once-daily
Number of subjects: 0
Study 36429797 — intervention group
Group type: EXPERIMENTAL
Intervention: Directed vestibular rehabilitation therapy (VRT) plus manual therapy (MT) once a week for 4 weeks
Number of subjects: 80
Study 36429797 — intervention group
Group type: COMPARATOR
Intervention: Directed vestibular rehabilitation therapy (VRT)
Number of subjects: 80
Study 36429797 — intervention group
Group type: EXPERIMENTAL
Intervention: Directed vestibular rehabilitation therapy (VRT) plus manual therapy (MT)
Number of subjects: 80
Study 34222637 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasocystic irrigation with hydrogen peroxide (H2O2)
Number of subjects: 50
Study 34222637 — intervention group
Group type: COMPARATOR
Intervention: Biflanged metal stent (BMS)
Number of subjects: 50
Study 32940630 — intervention group
Group type: EXPERIMENTAL
Intervention: Willingness to discuss clinical trials
Number of subjects: 205
Study 32940630 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based medical suspicion
Number of subjects: 205
Study 32940630 — intervention group
Group type: COMPARATOR
Intervention: Demographic comparisons
Number of subjects: 205
Study 35357104 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice at early supper (5:00 p.m.)
Number of subjects: 34
Study 35357104 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice at breakfast (8:00 a.m.)
Number of subjects: 34
Study 35357104 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice at lunch (12:30 p.m.)
Number of subjects: 34
Study 35357104 — intervention group
Group type: COMPARATOR
Intervention: Rice meals (all times)
Number of subjects: 34
Study 33024299 — intervention group
Group type: EXPERIMENTAL
Intervention: Real tDCS
Number of subjects: 12
Study 33024299 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 12
Study 33856385 — intervention group
Group type: EXPERIMENTAL
Intervention: ERAS group
Number of subjects: 370
Study 33856385 — intervention group
Group type: COMPARATOR
Intervention: Conventional group
Number of subjects: 370
Study 32305871 — intervention group
Group type: EXPERIMENTAL
Intervention: High triterpenic acid content olive oil
Number of subjects: 0
Study 32305871 — intervention group
Group type: COMPARATOR
Intervention: Low triterpenic acid content olive oil
Number of subjects: 0
Study 32305871 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentacyclic triterpenes consumption
Number of subjects: 0
Study 34778910 — intervention group
Group type: EXPERIMENTAL
Intervention: High HRSc (≥70%)
Number of subjects: 1471
Study 34778910 — intervention group
Group type: EXPERIMENTAL
Intervention: High MIHR (>70 bpm)
Number of subjects: 1471
Study 34778910 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous HRSc increase
Number of subjects: 1471
Study 34778910 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous MIHR increase
Number of subjects: 1471
Study 34934126 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin Resistance (IR)
Number of subjects: 835
Study 35950566 — intervention group
Group type: EXPERIMENTAL
Intervention: Selpercatinib
Number of subjects: 0
Study 35950566 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35491558 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 30
Study 35491558 — intervention group
Group type: COMPARATOR
Intervention: Sham (placebo) treatment
Number of subjects: 30